The Manitoba government is investing 16.8 million dollars into new research facilities at the University of Manitoba.

 

The funding will support the construction of two biological research centres aimed at boosting innovation, job creation, and hands-on learning for students.

 

One facility, the Prairie Biologics Accelerator at the Fort Garry campus, will focus on vaccine development and Bio-manufacturing.

 

The second, the One Health Emerging Respiratory Disease Centre at the Bannatyne campus, will feature secure labs for testing and research on high-risk pathogens.

 

The province says the investment will strengthen Manitoba’s role in biotechnology and pandemic preparedness, while creating new opportunities for researchers and students.